Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor

Documenti analoghi

• Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo
  di: Montano, Ryan, et al.
  Pubblicazione: (2013)
• The Mre11 nuclease is critical for the sensitivity of cells to Chk1 inhibition.
  di: Ruth Thompson, et al.
  Pubblicazione: (2012-01-01)
• The Mre11 Nuclease Is Critical for the Sensitivity of Cells to Chk1 Inhibition
  di: Thompson, Ruth, et al.
  Pubblicazione: (2012)
• Monitoring Oxygen Levels in Orthotopic Human Glioma Xenograft Following Carbogen Inhalation and Chemotherapy by Implantable Resonator Based Oximetry
  di: Hou, Huagang, et al.
  Pubblicazione: (2014)
• Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entry
  di: Parsels, Leslie A., et al.
  Pubblicazione: (2016)